TCUBEit Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 4

TCUBEit General Information

Description

Operator of a biotechnology company intended to specialize in research and product development for cancer immunotherapy. The company is engaged in the discovery, development, and commercialization of T-cell receptor-based cellular therapeutics, enabling researchers to discover new personalized therapeutic cell-based therapies.

Contact Information

Website
www.tcubeit.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Sejong SB Plaza
  • Number 904
  • Sejong, 30100
  • South Korea
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Sejong SB Plaza
  • Number 904
  • Sejong, 30100
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TCUBEit Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 25-Aug-2022 Completed Generating Revenue
1. Seed Round 01-Dec-2020 Completed Generating Revenue
To view TCUBEit’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

TCUBEit Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

TCUBEit Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022080877-A1 Porous silica microrod preparation method capable of controlling shape and size Inactive 15-Oct-2020

TCUBEit Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TCUBEit Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bogwang Venture Investment Venture Capital Minority
Company K Partners Venture Capital Minority
IMM Investment Asset Manager Minority
Korea Investment Partners Venture Capital Minority
To view TCUBEit’s complete investors history, request access »

Ready to get started?

Request a free trial

TCUBEit FAQs

  • When was TCUBEit founded?

    TCUBEit was founded in 2019.

  • Where is TCUBEit headquartered?

    TCUBEit is headquartered in Sejong, South Korea.

  • What is the size of TCUBEit?

    TCUBEit has 12 total employees.

  • What industry is TCUBEit in?

    TCUBEit’s primary industry is Drug Discovery.

  • Is TCUBEit a private or public company?

    TCUBEit is a Private company.

  • What is TCUBEit’s current revenue?

    The current revenue for TCUBEit is .

  • Who are TCUBEit’s investors?

    Bogwang Venture Investment, Company K Partners, IMM Investment, and Korea Investment Partners have invested in TCUBEit.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process